# Nebulized Budesonide Combined With Systemic Corticosteroid in Acute Severe Asthma

> **NCT04016220** · PHASE1 · UNKNOWN · sponsor: **University of Monastir** · enrollment: 60 (estimated)

## Conditions studied

- Acute Asthma

## Interventions

- **DRUG:** Budesonide
- **DRUG:** normal saline

## Key facts

- **NCT ID:** NCT04016220
- **Lead sponsor:** University of Monastir
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-20
- **Primary completion:** 2019-12-20
- **Final completion:** 2020-05-20
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2019-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04016220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04016220, "Nebulized Budesonide Combined With Systemic Corticosteroid in Acute Severe Asthma". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT04016220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*